By John Burchell / March 25, 2019 Home / News / New Center for Spectroscopic Excellence JASCO Corporation (Tokyo Japan) is proud to announce a joint collaboration with the Department of Chemistry at the prestigious University of Pennsylvania (Philadelphia). The New Center for Spectroscopic Excellence was inaugurated at the end of March 2019. We are pleased to be working with the researchers... Read more
Serological testing plays critical role in helping diagnose patients with celiac disease WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Anti-TissueTransglutaminase (tTG) ELISA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The test system is designed to help clinicians confirm or exclude... Read more
March 20, 2019 Shimadzu Corporation (head office: Kyoto city; President and CEO: Teruhisa Ueda) announces the release of a Multi-Omic Data Analysis Package designed for metabolic engineering research applications. Using this package, measurement data from Shimadzu mass spectrometers can be loaded in the Garuda*1 open platform and automatically plotted on a metabolic map. The package can... Read more
Basel, 19 March 2019 FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved for the initial treatment of extensive-stage small cell lung cancer (ES-SCLC) First new initial treatment... Read more
FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow specific to... Read more
Basel, 11 March 2019 FDA grants Roche’s Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer This Tecentriq combination is the first cancer immunotherapy regimen approved for breast cancer Triple-negative breast cancer is an aggressive disease, with high unmet medical need Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced... Read more
Basel, 07 March 2019 Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions Application is being reviewed under FDA’s Real-Time Oncology Review pilot programme Combination was granted Breakthrough Therapy Designation, the fifth for Venclexta Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced... Read more
Burlington, Massachusetts, March 7, 2019 — MilliporeSigma is igniting student interest in science with its third annual Curiosity Cube® mobile science lab tour. “We’ve seen firsthand how the interactive learning that takes place inside the Curiosity Cube® can spark curiosity crucial for developing a passion for science,” said Udit Batra, CEO, MilliporeSigma. “We will continue to... Read more
Agilent and Imperial College London Strengthen Partnership Agilent Measurement Suite at Imperial to boost research in molecular sciences SANTA CLARA, Calif., March 6, 2019 Agilent Technologies Inc. (NYSE: A) and Imperial College London have announced that, as part of its ongoing collaboration, several state-of-the-art analytical instruments have been installed into the college’s Molecular Sciences Research... Read more
EDEN PRAIRIE, Minn., March 4, 2019 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today announced a research collaboration with the Sismo Lab at Universidad Mariano Gálvez in Guatemala City, Guatemala to create seismic simulation solutions that will help predict and minimize earthquake damage to... Read more